A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development but was shelved.
NS Pharma scores breakthrough therapy status for DMD therapy – Pharmaceutical Technology
Duchenne Muscular Dystrophy is one of the more prevalent genetic conditions – it affects 1 in every 3,500 male births worldwide. Image credit: Shutterstock/ChiccoDodiFC The
July 28, 2023